Reider Paul 4
4 · Coherus BioSciences, Inc. · Filed Jul 24, 2024
Insider Transaction Report
Form 4
Reider Paul
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-07-22+40,000→ 40,000 totalExercise: $2.41Exp: 2034-04-11→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]On April 11, 2024 the Reporting Person was granted a performance stock option to purchase 200,000 shares of common stock, of which 40,000 of the shares vested and became exercisable on July 22, 2024 in connection with the Closing of the sale of Coherus BioSciences, Inc.'s YUSIMRY franchise.